安进的TCE双抗这次完胜肺癌之王——小细胞肺癌了。虽说都是肺癌，但是小细胞肺癌（SCLC）比非小细胞肺癌（NSCLC）恶性程度高太多。而安进首款针对实体瘤的双抗——Tarlatamab继去年读出二期临床的惊艳疗效提前获批后，如今在三期临床试验也达到了 ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

The adaptive immune system depends on the ability to assemble rearranged genes for both the T-cell receptor (TCR) and the immunoglobulin gene. This ability results from two genes known as RAG-1 ...